|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
42.650 +1.000 (+2.401%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 974,365 | 21.288% | 803,347 | 553,556 | 139,419 | 100,992 |
| Land & other Lease Assets | 73,740 | -18.420% | 90,390 | 30,878 | 38,111 | 23,823 |
| Intangible Assets | 9,748 | 778.198% | 1,110 | 1,496 | 1,104 | 109 |
| Interests in Asso. & JCEs | 566 | -90.278% | 5,822 | 10,570 | 20,281 | 0 |
| Other Non-current Assets | 242,121 | 466.736% | 42,722 | 25,842 | 153,591 | 24,104 |
| 1,300,540 | 37.858% | 943,391 | 622,342 | 352,506 | 149,028 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 111,422 | 97.718% | 56,354 | 44,495 | 16,393 | 6,846 | |
| Trade Receivables | 62,851 | 290.597% | 16,091 | 0 | 0 | 0 | |
| Cash & Bank Balances | 418,413 | -50.834% | 851,029 | 604,070 | 1,520,619 | 199,409 | |
| Other Current Assets | 1,873,340 | -7.079% | 2,016,057 | 2,661,409 | 2,044,937 | 174,662 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 2,466,026 | -16.108% | 2,939,531 | 3,309,974 | 3,581,949 | 380,917 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 26,007 | -11.805% | 29,488 | 14,913 | 2,784 | 3,418 | ||
| S-T Debt & Leases | 484,735 | 642.866% | 65,252 | 72,241 | 11,724 | 4,178 | ||
| Other Current Liabilities | 236,984 | 7.995% | 219,440 | 292,545 | 97,567 | 72,644 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 747,726 | 137.993% | 314,180 | 379,699 | 112,075 | 80,240 | |||
| Net Current Assets | 1,718,300 | -34.550% | 2,625,351 | 2,930,275 | 3,469,874 | 300,677 | ||
| Total Assets Less Current Liabilities | 3,018,840 | -15.409% | 3,568,742 | 3,552,617 | 3,822,380 | 449,705 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 268,503 | -24.035% | 353,457 | 49,728 | 26,985 | 20,314 | |||
| Other Non-current Liabilities | 275,125 | 20.420% | 228,472 | 163,671 | 150,013 | 1,524,194 | |||
| 543,628 | -6.582% | 581,929 | 213,399 | 176,998 | 1,544,508 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 174 | 2.959% | 169 | 170 | 171 | 45 | ||||
| Reserves | 2,474,397 | -17.137% | 2,986,142 | 3,340,118 | 3,650,799 | (1,094,583) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 2,474,571 | -17.136% | 2,986,311 | 3,340,288 | 3,650,970 | (1,094,538) | ||||
| Non-controlling Interests | 641 | 27.689% | 502 | (1,070) | (5,588) | (265) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 2,475,212 | -17.129% | 2,986,813 | 3,339,218 | 3,645,382 | (1,094,803) | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 228,008 | 897 | 254,345 | 1,970 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 17/04/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -515,241,000 |
| %Change | 43.379% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 8.846 |